{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T07:28:17Z","timestamp":1791098897580,"version":"4.1.0"},"reference-count":390,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,20]],"date-time":"2014-11-20T00:00:00Z","timestamp":1416441600000},"content-version":"vor","delay-in-days":415,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"European Research Community Funds to PTPNET","award":["MRTN-CT-2006-035830"],"award-info":[{"award-number":["MRTN-CT-2006-035830"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.bbadis.2013.05.022","type":"journal-article","created":{"date-parts":[[2013,5,24]],"date-time":"2013-05-24T00:02:26Z","timestamp":1369353746000},"page":"1673-1696","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":103,"title":["Protein tyrosine phosphatase variants in human hereditary disorders and disease susceptibilities"],"prefix":"10.1016","volume":"1832","author":[{"given":"Wiljan J.A.J.","family":"Hendriks","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Pulido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2013.05.022_bb0630","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.cell.2010.08.023","article-title":"Phosphotyrosine signaling: evolving a new cellular communication system","volume":"142","author":"Lim","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2013.05.022_bb0635","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/ajmg.10775","article-title":"FGFs, their receptors, and human limb malformations: clinical and molecular correlations","volume":"112","author":"Wilkie","year":"2002","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0640","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/j.1742-4658.2008.06249.x","article-title":"Protein tyrosine phosphatases: functional inferences from mouse models and human diseases","volume":"275","author":"Hendriks","year":"2008","journal-title":"FEBS J."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0645","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1111\/febs.12000","article-title":"Protein tyrosine phosphatases in health and disease","volume":"280","author":"Hendriks","year":"2013","journal-title":"FEBS J."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0650","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/febs.12077","article-title":"Protein tyrosine phosphatases: from housekeeping enzymes to master-regulators of signal transduction","volume":"280","author":"Tonks","year":"2013","journal-title":"FEBS J."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0655","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nrc2980","article-title":"Inside the human cancer tyrosine phosphatome","volume":"11","author":"Julien","year":"2011","journal-title":"Nat. Rev."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0660","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00401-009-0614-0","article-title":"Protein tyrosine phosphatases in glioma biology","volume":"119","author":"Navis","year":"2010","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0665","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2174\/187152011794941190","article-title":"Dual-specificity MAP kinase phosphatases as targets of cancer treatment","volume":"11","author":"Nunes-Xavier","year":"2011","journal-title":"Anticancer Agents Med. Chem."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0670","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/j.1742-4658.2008.06250.x","article-title":"Protein tyrosine phosphatases: dual-specificity phosphatases in health and disease","volume":"275","author":"Pulido","year":"2008","journal-title":"FEBS J."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0675","doi-asserted-by":"crossref","first-page":"C189","DOI":"10.1152\/ajpcell.00347.2009","article-title":"The dual-specificity MAP kinase phosphatases: critical roles in development and cancer","volume":"299","author":"Bermudez","year":"2010","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0680","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.cell.2004.05.018","article-title":"Protein tyrosine phosphatases in the human genome","volume":"117","author":"Alonso","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2013.05.022_bb0685","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1096\/fj.02-1212rev","article-title":"A genomic perspective on protein tyrosine phosphatases: gene structure, pseudogenes, and genetic disease linkage","volume":"18","author":"Andersen","year":"2004","journal-title":"FASEB J."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0690","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s13277-010-0075-z","article-title":"CDC 25A gene 263C\/T, \u2212350C\/T, and \u221251C\/G polymorphisms in breast carcinoma","volume":"31","author":"Karagoz","year":"2010","journal-title":"Tumour Biol."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0695","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/MAJ.0b013e31823e5cfa","article-title":"Acid phosphatase locus 1 genetic polymorphism and cancer grading","volume":"344","author":"Gloria-Bottini","year":"2012","journal-title":"Am. J. Med. Sci."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0700","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1159\/000203405","article-title":"ACP1 genetic polymorphism and coronary artery disease: an association study","volume":"113","author":"Banci","year":"2009","journal-title":"Cardiology"},{"key":"10.1016\/j.bbadis.2013.05.022_bb0705","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1007\/s00018-008-8501-8","article-title":"From immune response to cancer: a spot on the low molecular weight protein tyrosine phosphatase","volume":"66","author":"Souza","year":"2009","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0710","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.cancergencyto.2007.11.004","article-title":"Low molecular weight protein tyrosine phosphatase genetic polymorphism and susceptibility to cancer development","volume":"181","author":"Alho","year":"2008","journal-title":"Cancer Genet. Cytogenet."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0715","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1055\/s-0029-1202834","article-title":"Genetic polymorphism and idiopathic generalized epilepsy. Evidence of interaction between haptoglobin and ACP1 systems","volume":"39","author":"Gloria-Bottini","year":"2008","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.bbadis.2013.05.022_bb0720","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/jcp.24128","article-title":"TULA-family proteins: a new class of cellular regulators","volume":"228","author":"Tsygankov","year":"2013","journal-title":"J. Cell. Physiol."},{"issue":"2","key":"10.1016\/j.bbadis.2013.05.022_bb0725","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1742-4658.2012.08563.x","article-title":"PTP1B and TCPTP\u2014nonredundant phosphatases in insulin signaling and glucose homeostasis","volume":"280","author":"Tiganis","year":"2013","journal-title":"FEBS J."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0730","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1086\/339270","article-title":"A variation in 3\u2032 UTR of hPTP1B increases specific gene expression and associates with insulin resistance","volume":"70","author":"Di Paola","year":"2002","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0735","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1210\/jcem.87.2.8253","article-title":"A single nucleotide polymorphism in protein tyrosine phosphatase PTP-1B is associated with protection from diabetes or impaired glucose tolerance in Oji-Cree","volume":"87","author":"Mok","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0740","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2337\/diabetes.51.1.1","article-title":"A P387L variant in protein tyrosine phosphatase-1B (PTP-1B) is associated with type 2 diabetes and impaired serine phosphorylation of PTP-1B in vitro","volume":"51","author":"Echwald","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.bbadis.2013.05.022_bb0745","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.2337\/diabetes.53.11.3013","article-title":"Association of protein tyrosine phosphatase 1B gene polymorphisms with measures of glucose homeostasis in Hispanic Americans: the insulin resistance atherosclerosis study (IRAS) family study","volume":"53","author":"Palmer","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.bbadis.2013.05.022_bb0750","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/oby.2005.95","article-title":"Protein tyrosine phosphatase 1B variant associated with fat distribution and insulin metabolism","volume":"13","author":"Ukkola","year":"2005","journal-title":"Obes. Res."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0755","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.2337\/diabetes.53.11.3007","article-title":"Association of protein tyrosine phosphatase 1B gene polymorphisms with type 2 diabetes","volume":"53","author":"Bento","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.bbadis.2013.05.022_bb0760","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.tibs.2010.03.004","article-title":"PTP1B: a double agent in metabolism and oncogenesis","volume":"35","author":"Yip","year":"2010","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0765","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1126\/science.283.5407.1544","article-title":"Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene","volume":"283","author":"Elchebly","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2013.05.022_bb0770","doi-asserted-by":"crossref","first-page":"5479","DOI":"10.1128\/MCB.20.15.5479-5489.2000","article-title":"Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in protein-tyrosine phosphatase 1B-deficient mice","volume":"20","author":"Klaman","year":"2000","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0775","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1002\/hep.25912","article-title":"Decrease of microRNA-122 causes hepatic insulin resistance by inducing protein tyrosine phosphatase 1B, which is reversed by licorice flavonoid","volume":"56","author":"Yang","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2013.05.022_bb0780","doi-asserted-by":"crossref","first-page":"11357","DOI":"10.1073\/pnas.142298199","article-title":"PTP1B antisense oligonucleotide lowers PTP1B protein, normalizes blood glucose, and improves insulin sensitivity in diabetic mice","volume":"99","author":"Zinker","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0785","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1210\/en.2008-0885","article-title":"Inhibition of protein tyrosine phosphatase-1B with antisense oligonucleotides improves insulin sensitivity and increases adiponectin concentrations in monkeys","volume":"150","author":"Swarbrick","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbadis.2013.05.022_bb0790","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.2337\/diabetes.54.6.1884","article-title":"Association testing of the protein tyrosine phosphatase 1B gene (PTPN1) with type 2 diabetes in 7,883 people","volume":"54","author":"Florez","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.bbadis.2013.05.022_bb0795","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1365-2796.2004.01446.x","article-title":"The Pro387Leu variant of protein tyrosine phosphatase-1B is not associated with diabetes mellitus type 2 in a German population","volume":"257","author":"Gouni-Berthold","year":"2005","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0800","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/BF03346629","article-title":"Protein tyrosine phosphatase 1B gene polymorphisms and essential hypertension: a case\u2013control study in Chinese population","volume":"33","author":"Gu","year":"2010","journal-title":"J. Endocrinol. Invest."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0805","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/HJR.0b013e32832d30c4","article-title":"PTPN1 polymorphisms are associated with total and low-density lipoprotein cholesterol","volume":"17","author":"Bauer","year":"2010","journal-title":"Eur. J. Cardiovasc. Prev. Rehabil."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0810","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1093\/hmg\/ddh196","article-title":"Single nucleotide polymorphisms in protein tyrosine phosphatase 1beta (PTPN1) are associated with essential hypertension and obesity","volume":"13","author":"Olivier","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0815","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1073\/pnas.89.2.499","article-title":"Cloning and characterization of a mouse cDNA encoding a cytoplasmic protein-tyrosine-phosphatase","volume":"89","author":"Mosinger","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0820","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1083\/jcb.131.3.631","article-title":"COOH-terminal sequence motifs target the T cell protein tyrosine phosphatase to the ER and nucleus","volume":"131","author":"Lorenzen","year":"1995","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0825","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/ng.587","article-title":"Deletion of the protein tyrosine phosphatase gene PTPN2 in T-cell acute lymphoblastic leukemia","volume":"42","author":"Kleppe","year":"2010","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0830","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nature05911","article-title":"Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls","volume":"447","author":"Consortium","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2013.05.022_bb0835","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00251-010-0500-x","article-title":"A polymorphism in PTPN2 gene is associated with an earlier onset of type 1 diabetes","volume":"63","author":"Espino-Paisan","year":"2011","journal-title":"Immunogenetics"},{"key":"10.1016\/j.bbadis.2013.05.022_bb0840","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1038\/ng.175","article-title":"Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease","volume":"40","author":"Barrett","year":"2008","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0845","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1002\/ibd.21651","article-title":"Meta-analysis of published studies identified eight additional common susceptibility loci for Crohn's disease and ulcerative colitis","volume":"17","author":"Umeno","year":"2011","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0850","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1600-065X.2008.00743.x","article-title":"T-cell protein tyrosine phosphatase is a key regulator in immune cell signaling: lessons from the knockout mouse model and implications in human disease","volume":"228","author":"Doody","year":"2009","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0855","doi-asserted-by":"crossref","first-page":"e36703","DOI":"10.1371\/journal.pone.0036703","article-title":"Strain-dependent differences in bone development, myeloid hyperplasia, morbidity and mortality in ptpn2-deficient mice","volume":"7","author":"Wiede","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2013.05.022_bb0860","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/gene.2010.54","article-title":"An autoimmune-associated variant in PTPN2 reveals an impairment of IL-2R signaling in CD4(+) T cells","volume":"12","author":"Long","year":"2011","journal-title":"Genes Immun."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0865","doi-asserted-by":"crossref","first-page":"4758","DOI":"10.1172\/JCI59492","article-title":"T cell protein tyrosine phosphatase attenuates T cell signaling to maintain tolerance in mice","volume":"121","author":"Wiede","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0870","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1002\/ibd.21891","article-title":"Protein tyrosine phosphatase nonreceptor type 2 regulates autophagosome formation in human intestinal cells","volume":"18","author":"Scharl","year":"2012","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0875","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.tins.2006.06.007","article-title":"Synaptic plasticity: one STEP at a time","volume":"29","author":"Braithwaite","year":"2006","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0880","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1111\/j.1460-9568.2011.07687.x","article-title":"Striatal-enriched protein tyrosine phosphatase (STEP) knockout mice have enhanced hippocampal memory","volume":"33","author":"Venkitaramani","year":"2011","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0885","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/syn.20608","article-title":"Knockout of striatal enriched protein tyrosine phosphatase in mice results in increased ERK1\/2 phosphorylation","volume":"63","author":"Venkitaramani","year":"2009","journal-title":"Synapse"},{"key":"10.1016\/j.bbadis.2013.05.022_bb0890","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1124\/pr.110.003053","article-title":"Therapeutic implications for striatal-enriched protein tyrosine phosphatase (STEP) in neuropsychiatric disorders","volume":"64","author":"Goebel-Goody","year":"2012","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0895","doi-asserted-by":"crossref","first-page":"4746","DOI":"10.1073\/pnas.081071198","article-title":"Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia","volume":"98","author":"Hakak","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0900","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.pneurobio.2010.09.004","article-title":"Linking oligodendrocyte and myelin dysfunction to neurocircuitry abnormalities in schizophrenia","volume":"93","author":"Takahashi","year":"2011","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0905","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/YPG.0b013e3283518586","article-title":"Involvement of PTPN5, the gene encoding the striatal-enriched protein tyrosine phosphatase, in schizophrenia and cognition","volume":"22","author":"Pelov","year":"2012","journal-title":"Psychiatr. Genet."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0910","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S0968-0004(03)00091-4","article-title":"The \u2018Shp\u2019ing news: SH2 domain-containing tyrosine phosphatases in cell signaling","volume":"28","author":"Neel","year":"2003","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0915","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0167-7799(97)01060-3","article-title":"Severe defects in immunity and hematopoiesis caused by SHP-1 protein-tyrosine-phosphatase deficiency","volume":"15","author":"Shultz","year":"1997","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0920","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1146\/annurev.immunol.23.021704.115647","article-title":"Nonreceptor protein-tyrosine phosphatases in immune cell signaling","volume":"25","author":"Pao","year":"2007","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0925","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1006\/smim.2000.0223","article-title":"Roles of the SHP-1 tyrosine phosphatase in the negative regulation of cell signalling","volume":"12","author":"Zhang","year":"2000","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0930","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/j.ajpath.2010.12.035","article-title":"Alteration in the gene encoding protein tyrosine phosphatase nonreceptor type 6 (PTPN6\/SHP1) may contribute to neutrophilic dermatoses","volume":"178","author":"Nesterovitch","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0935","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1016\/j.ajpath.2010.12.053","article-title":"Spontaneous insertion of a b2 element in the ptpn6 gene drives a systemic autoinflammatory disease in mice resembling neutrophilic dermatosis in humans","volume":"178","author":"Nesterovitch","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0940","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.tips.2006.08.005","article-title":"MAPK-specific tyrosine phosphatases: new targets for drug discovery?","volume":"27","author":"Barr","year":"2006","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0945","doi-asserted-by":"crossref","first-page":"6851","DOI":"10.1128\/MCB.21.20.6851-6858.2001","article-title":"Hematopoietic protein tyrosine phosphatase suppresses extracellular stimulus-regulated kinase activation","volume":"21","author":"Gronda","year":"2001","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0950","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/jhg.2010.88","article-title":"Genetic variants that affect length\/height in infancy\/early childhood in Vietnamese-Korean families","volume":"55","author":"Kim","year":"2010","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0955","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1007\/s00018-007-6509-0","article-title":"How do Shp2 mutations that oppositely influence its biochemical activity result in syndromes with overlapping symptoms?","volume":"64","author":"Edouard","year":"2007","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0960","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0065-230X(10)06002-1","article-title":"The tyrosine phosphatase Shp2 in development and cancer","volume":"106","author":"Grossmann","year":"2010","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0965","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.gde.2006.12.011","article-title":"The role of Shp2 (PTPN11) in cancer","volume":"17","author":"Mohi","year":"2007","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0970","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1017\/S1462399408000902","article-title":"Noonan, Costello and cardio-facio-cutaneous syndromes: dysregulation of the Ras-MAPK pathway","volume":"10","author":"Tidyman","year":"2008","journal-title":"Expert Rev. Mol. Med."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0975","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1086\/499925","article-title":"Diversity and functional consequences of germline and somatic PTPN11 mutations in human disease","volume":"78","author":"Tartaglia","year":"2006","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0980","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0092-8674(00)80938-1","article-title":"Crystal structure of the tyrosine phosphatase SHP-2","volume":"92","author":"Hof","year":"1998","journal-title":"Cell"},{"issue":"Suppl. 2","key":"10.1016\/j.bbadis.2013.05.022_bb0985","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000243773","article-title":"Malignant diseases in Noonan syndrome and related disorders","volume":"72","author":"Hasle","year":"2009","journal-title":"Horm. Res."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0990","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/ejhg.2011.37","article-title":"Cancer risk in patients with Noonan syndrome carrying a PTPN11 mutation","volume":"19","author":"Jongmans","year":"2011","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0995","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ejmg.2005.03.001","article-title":"Germ-line and somatic PTPN11 mutations in human disease","volume":"48","author":"Tartaglia","year":"2005","journal-title":"Eur. J. Med. Genet."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1000","doi-asserted-by":"crossref","first-page":"10472","DOI":"10.1074\/jbc.M113.450023","article-title":"Structural and mechanistic insights into LEOPARD syndrome-associated SHP2 mutations","volume":"288","author":"Yu","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1005","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/ng1156","article-title":"Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia","volume":"34","author":"Tartaglia","year":"2003","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1010","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1073\/pnas.0237137100","article-title":"STAT3 deletion during hematopoiesis causes Crohn's disease-like pathogenesis and lethality: a critical role of STAT3 in innate immunity","volume":"100","author":"Welte","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1015","doi-asserted-by":"crossref","first-page":"22353","DOI":"10.1074\/jbc.M109.020495","article-title":"Negative regulation of Stat3 by activating PTPN11 mutants contributes to the pathogenesis of Noonan syndrome and juvenile myelomonocytic leukemia","volume":"284","author":"Zhang","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1020","doi-asserted-by":"crossref","first-page":"e1000991","DOI":"10.1371\/journal.pgen.1000991","article-title":"Whole-genome sequencing of a single proband together with linkage analysis identifies a Mendelian disease gene","volume":"6","author":"Sobreira","year":"2010","journal-title":"PLoS Genet."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1025","doi-asserted-by":"crossref","first-page":"e1002050","DOI":"10.1371\/journal.pgen.1002050","article-title":"Loss-of-function mutations in PTPN11 cause metachondromatosis, but not Ollier disease or Maffucci syndrome","volume":"7","author":"Bowen","year":"2011","journal-title":"PLoS Genet."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1030","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1161\/CIRCGENETICS.111.962035","article-title":"A common variant in the PTPN11 gene contributes to the risk of tetralogy of Fallot","volume":"5","author":"Goodship","year":"2012","journal-title":"Circ. Cardiovasc. Genet."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1035","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1600-065X.2008.00747.x","article-title":"PEST family phosphatases in immunity, autoimmunity, and autoinflammatory disorders","volume":"228","author":"Veillette","year":"2009","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1040","doi-asserted-by":"crossref","first-page":"15593","DOI":"10.1074\/jbc.R500030200","article-title":"Regulation of cell adhesion by protein-tyrosine phosphatases. I. Cell-matrix adhesion","volume":"281","author":"Burridge","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1045","article-title":"PTPN12 promotes resistance to oxidative stress and supports tumorigenesis by regulating FOXO signaling","author":"Harris","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.bbadis.2013.05.022_bb1050","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.cell.2011.02.003","article-title":"Activation of multiple proto-oncogenic tyrosine kinases in breast cancer via loss of the PTPN12 phosphatase","volume":"144","author":"Sun","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2013.05.022_bb1055","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.cancergencyto.2006.05.013","article-title":"PTP-PEST phosphatase variations in human cancer","volume":"170","author":"Streit","year":"2006","journal-title":"Cancer Genet. Cytogenet."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1060","doi-asserted-by":"crossref","first-page":"4789","DOI":"10.1046\/j.1432-1033.2003.03895.x","article-title":"The protein tyrosine phosphatase PTP-Basophil\/Basophil-like. Interacting proteins and molecular functions","volume":"270","author":"Erdmann","year":"2003","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1065","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.immuni.2007.01.010","article-title":"Regulation of signal transducer and activator of transcription signaling by the tyrosine phosphatase PTP-BL","volume":"26","author":"Nakahira","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.bbadis.2013.05.022_bb1070","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1152\/physiolgenomics.00079.2004","article-title":"Mild impairment of motor nerve repair in mice lacking PTP-BL tyrosine phosphatase activity","volume":"19","author":"Wansink","year":"2004","journal-title":"Physiol. Genomics"},{"key":"10.1016\/j.bbadis.2013.05.022_bb1075","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s10555-008-9114-2","article-title":"PTPL1: a large phosphatase with a split personality","volume":"27","author":"Abaan","year":"2008","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1080","doi-asserted-by":"crossref","first-page":"78","DOI":"10.2174\/187152011794941262","article-title":"PTPN13\/PTPL1: an important regulator of tumor aggressiveness","volume":"11","author":"Freiss","year":"2011","journal-title":"Anticancer Agents Med. Chem."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1085","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1158\/1078-0432.CCR-05-1383","article-title":"Genetic characterization of fas-associated phosphatase-1 as a putative tumor suppressor gene on chromosome 4q21.3 in hepatocellular carcinoma","volume":"12","author":"Yeh","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1090","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1093\/carcin\/bgp265","article-title":"Genetic polymorphisms in the PTPN13 gene and risk of squamous cell carcinoma of head and neck","volume":"30","author":"Niu","year":"2009","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bbadis.2013.05.022_bb1095","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00432-009-0656-7","article-title":"Missense polymorphisms of PTPRJ and PTPN13 genes affect susceptibility to a variety of human cancers","volume":"136","author":"Mita","year":"2010","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1100","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1038\/sj.onc.1210922","article-title":"Protein tyrosine phosphatase PTPN13 negatively regulates Her2\/ErbB2 malignant signaling","volume":"27","author":"Zhu","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.bbadis.2013.05.022_bb1105","doi-asserted-by":"crossref","first-page":"3960","DOI":"10.1038\/onc.2009.251","article-title":"Impaired PTPN13 phosphatase activity in spontaneous or HPV-induced squamous cell carcinomas potentiates oncogene signaling through the MAP kinase pathway","volume":"28","author":"Hoover","year":"2009","journal-title":"Oncogene"},{"key":"10.1016\/j.bbadis.2013.05.022_bb1110","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.ajhg.2010.08.008","article-title":"Protein tyrosine phosphatase PTPN14 is a regulator of lymphatic function and choanal development in humans","volume":"87","author":"Au","year":"2010","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1115","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/ncomms1633","article-title":"Mouse and human strategies identify PTPN14 as a modifier of angiogenesis and hereditary haemorrhagic telangiectasia","volume":"3","author":"Benzinou","year":"2012","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1120","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.cub.2012.01.019","article-title":"Drosophila Pez acts in Hippo signaling to restrict intestinal stem cell proliferation","volume":"22","author":"Poernbacher","year":"2012","journal-title":"Curr. Biol."},{"issue":"10","key":"10.1016\/j.bbadis.2013.05.022_bb1125","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1038\/onc.2012.147","article-title":"PTPN14 interacts with and negatively regulates the oncogenic function of YAP","volume":"32","author":"Liu","year":"2013","journal-title":"Oncogene"},{"issue":"17","key":"10.1016\/j.bbadis.2013.05.022_bb1130","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1038\/onc.2012.231","article-title":"YAP modifies cancer cell sensitivity to EGFR and survivin inhibitors and is negatively regulated by the non-receptor type protein tyrosine phosphatase 14","volume":"32","author":"Huang","year":"2013","journal-title":"Oncogene"},{"issue":"17","key":"10.1016\/j.bbadis.2013.05.022_bb1135","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1101\/gad.192955.112","article-title":"PTPN14 is required for the density-dependent control of YAP1","volume":"26","author":"Wang","year":"2012","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1140","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.schres.2011.06.023","article-title":"Two non-synonymous markers in PTPN21, identified by genome-wide association study data-mining and replication, are associated with schizophrenia","volume":"131","author":"Chen","year":"2011","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1145","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1086\/422827","article-title":"A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis","volume":"75","author":"Begovich","year":"2004","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1150","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/ng1323","article-title":"A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes","volume":"36","author":"Bottini","year":"2004","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1155","doi-asserted-by":"crossref","first-page":"3689","DOI":"10.1016\/j.febslet.2011.04.032","article-title":"Why is PTPN22 a good candidate susceptibility gene for autoimmune disease?","volume":"585","author":"Burn","year":"2011","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1160","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1080\/08916930701464897","article-title":"Protein tyrosine phosphatase PTPN22 in human autoimmunity","volume":"40","author":"Vang","year":"2007","journal-title":"Autoimmunity"},{"key":"10.1016\/j.bbadis.2013.05.022_bb1165","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/jid.2008.297","article-title":"Further genetic evidence for three psoriasis-risk genes: ADAM33, CDKAL1, and PTPN22","volume":"129","author":"Li","year":"2009","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1170","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1002\/ibd.21630","article-title":"Differential association of two PTPN22 coding variants with Crohn's disease and ulcerative colitis","volume":"17","author":"Diaz-Gallo","year":"2011","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1175","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1136\/ard.2010.130138","article-title":"Analysis of the influence of PTPN22 gene polymorphisms in systemic sclerosis","volume":"70","author":"Diaz-Gallo","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1180","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.1399-0039.2009.01304.x","article-title":"Association of PTPN22 gene functional variants with development of pulmonary tuberculosis in Moroccan population","volume":"74","author":"Lamsyah","year":"2009","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.bbadis.2013.05.022_bb1185","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1126\/science.1092138","article-title":"PEST domain-enriched tyrosine phosphatase (PEP) regulation of effector\/memory T cells","volume":"303","author":"Hasegawa","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2013.05.022_bb1190","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1038\/ng1673","article-title":"Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of-function variant","volume":"37","author":"Vang","year":"2005","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1195","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1038\/ng.904","article-title":"The autoimmune disease-associated PTPN22 variant promotes calpain-mediated Lyp\/Pep degradation associated with lymphocyte and dendritic cell hyperresponsiveness","volume":"43","author":"Zhang","year":"2011","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1200","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.leukres.2011.06.011","article-title":"Functional polymorphisms in SOCS1 and PTPN22 genes correlate with the response to imatinib treatment in newly diagnosed chronic-phase chronic myeloid leukemia","volume":"36","author":"Guillem","year":"2012","journal-title":"Leuk. Res."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1205","doi-asserted-by":"crossref","first-page":"11002","DOI":"10.1074\/jbc.M600498200","article-title":"Identification of substrates of human protein-tyrosine phosphatase PTPN22","volume":"281","author":"Wu","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1210","doi-asserted-by":"crossref","first-page":"30526","DOI":"10.1074\/jbc.M111.254722","article-title":"Substrate specificity of lymphoid-specific tyrosine phosphatase (Lyp) and identification of Src kinase-associated protein of 55kDa homolog (SKAP-HOM) as a Lyp substrate","volume":"286","author":"Yu","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1215","doi-asserted-by":"crossref","first-page":"5267","DOI":"10.4049\/jimmunol.1200150","article-title":"PTPN22 alters the development of regulatory T cells in the thymus","volume":"188","author":"Maine","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1220","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1083\/jcb.200803045","article-title":"NCAM induces CaMKIIalpha-mediated RPTPalpha phosphorylation to enhance its catalytic activity and neurite outgrowth","volume":"182","author":"Bodrikov","year":"2008","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1225","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/sj.emboj.7601939","article-title":"Neural recognition molecules CHL1 and NB-3 regulate apical dendrite orientation in the neocortex via PTP alpha","volume":"27","author":"Ye","year":"2008","journal-title":"EMBO J."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1230","doi-asserted-by":"crossref","first-page":"26071","DOI":"10.1074\/jbc.M110.214080","article-title":"Receptor-like protein-tyrosine phosphatase alpha enhances cell surface expression of neural adhesion molecule NB-3","volume":"286","author":"Ye","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1235","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1083\/jcb.147.4.707","article-title":"Protein tyrosine phosphatase alpha (PTPalpha) and contactin form a novel neuronal receptor complex linked to the intracellular tyrosine kinase fyn","volume":"147","author":"Zeng","year":"1999","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1240","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0960-9822(99)80234-6","article-title":"Receptor protein tyrosine phosphatase alpha activates Src-family kinases and controls integrin-mediated responses in fibroblasts","volume":"9","author":"Su","year":"1999","journal-title":"Curr. Biol."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1245","doi-asserted-by":"crossref","first-page":"35815","DOI":"10.1074\/jbc.M807964200","article-title":"Activation of c-Src and Fyn kinases by protein-tyrosine phosphatase RPTPalpha is substrate-specific and compatible with lipid raft localization","volume":"283","author":"Vacaresse","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1250","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.biopsych.2011.06.016","article-title":"Loss of function studies in mice and genetic association link receptor protein tyrosine phosphatase alpha to schizophrenia","volume":"70","author":"Takahashi","year":"2011","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbadis.2013.05.022_bb1255","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/mp.2009.124","article-title":"Genome-wide association study of recurrent early-onset major depressive disorder","volume":"16","author":"Shi","year":"2011","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bbadis.2013.05.022_bb1260","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1523\/JNEUROSCI.21-06-02039.2001","article-title":"A unique role for Fyn in CNS myelination","volume":"21","author":"Sperber","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1265","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.expneurol.2010.08.002","article-title":"Regulation of peripheral myelination by Src-like kinases","volume":"226","author":"Hossain","year":"2010","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1270","doi-asserted-by":"crossref","first-page":"23517","DOI":"10.1016\/S0021-9258(18)54311-8","article-title":"CD45. A prototype for transmembrane protein tyrosine phosphatases","volume":"266","author":"Trowbridge","year":"1991","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1275","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1126\/science.1650499","article-title":"Protein tyrosine phosphatases: a diverse family of intracellular and transmembrane enzymes","volume":"253","author":"Fischer","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2013.05.022_bb1280","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1006\/smim.2000.0218","article-title":"The CD45 tyrosine phosphatase: a positive and negative regulator of immune cell function","volume":"12","author":"Alexander","year":"2000","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1285","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1146\/annurev.immunol.21.120601.140946","article-title":"CD45: a critical regulator of signaling thresholds in immune cells","volume":"21","author":"Hermiston","year":"2003","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1290","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.chom.2009.07.003","article-title":"Reduced levels of protein tyrosine phosphatase CD45 protect mice from the lethal effects of Ebola virus infection","volume":"6","author":"Panchal","year":"2009","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.bbadis.2013.05.022_bb1295","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/73208","article-title":"Mutations in the tyrosine phosphatase CD45 gene in a child with severe combined immunodeficiency disease","volume":"6","author":"Kung","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1300","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.4049\/jimmunol.166.2.1308","article-title":"A deletion in the gene encoding the CD45 antigen in a patient with SCID","volume":"166","author":"Tchilian","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1305","doi-asserted-by":"crossref","first-page":"10456","DOI":"10.1073\/pnas.1202249109","article-title":"CD45-deficient severe combined immunodeficiency caused by uniparental disomy","volume":"109","author":"Roberts","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1310","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.neulet.2004.12.066","article-title":"Involvement of CD45 in central nervous system myelination","volume":"379","author":"Nakahara","year":"2005","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1315","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/82659","article-title":"A point mutation in PTPRC is associated with the development of multiple sclerosis","volume":"26","author":"Jacobsen","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1320","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1002\/eji.1830250745","article-title":"A point mutation in the human CD45 gene associated with defective splicing of exon A","volume":"25","author":"Thude","year":"1995","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1325","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.brainres.2008.12.017","article-title":"An investigation of the C77G and C772T variations within the human protein tyrosine phosphatase receptor type C gene for association with multiple sclerosis in an Australian population","volume":"1255","author":"Szvetko","year":"2009","journal-title":"Brain Res."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1330","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1136\/jmg.2005.040485","article-title":"Altered CD45 expression in C77G carriers influences immune function and outcome of hepatitis C infection","volume":"43","author":"Dawes","year":"2006","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1335","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1038\/ng.479","article-title":"Genetic variants at CD28, PRDM1 and CD2\/CD58 are associated with rheumatoid arthritis risk","volume":"41","author":"Raychaudhuri","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1340","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/art.33381","article-title":"Replication of association of the PTPRC gene with response to anti-tumor necrosis factor therapy in a large UK cohort","volume":"64","author":"Plant","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1840","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1002\/art.27457","article-title":"Rheumatoid arthritis risk allele PTPRC is also associated with response to anti-tumor necrosis factor alpha therapy","volume":"62","author":"Cui","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1845","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s00415-009-0134-9","article-title":"Recent advances in the diagnosis, genetics and treatment of restless legs syndrome","volume":"256","author":"Trenkwalder","year":"2009","journal-title":"J. Neurol."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1850","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1212\/01.wnl.0000282760.07650.ba","article-title":"Evidence for linkage of restless legs syndrome to chromosome 9p: are there two distinct loci?","volume":"70","author":"Lohmann-Hedrich","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2013.05.022_bb1855","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/ng.190","article-title":"PTPRD (protein tyrosine phosphatase receptor type delta) is associated with restless legs syndrome","volume":"40","author":"Schormair","year":"2008","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1860","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/mds.23459","article-title":"Family-based and population-based association studies validate PTPRD as a risk factor for restless legs syndrome","volume":"26","author":"Yang","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1865","doi-asserted-by":"crossref","first-page":"5872","DOI":"10.1523\/JNEUROSCI.0386-06.2006","article-title":"Mammalian motoneuron axon targeting requires receptor protein tyrosine phosphatases sigma and delta","volume":"26","author":"Uetani","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1870","doi-asserted-by":"crossref","first-page":"4797","DOI":"10.1093\/hmg\/ddr418","article-title":"The X-linked intellectual disability protein IL1RAPL1 regulates excitatory synapse formation by binding PTPdelta and RhoGAP2","volume":"20","author":"Valnegri","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1875","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.gene.2012.09.094","article-title":"Polymorphism in protein tyrosine phosphatase receptor delta is associated with the risk of clear cell renal cell carcinoma","volume":"512","author":"Du","year":"2013","journal-title":"Gene"},{"key":"10.1016\/j.bbadis.2013.05.022_bb1880","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1038\/ejhg.2008.79","article-title":"The polymorphisms of protein-tyrosine phosphatase receptor-type delta gene and its association with pediatric asthma in the Taiwanese population","volume":"16","author":"Shyur","year":"2008","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1885","doi-asserted-by":"crossref","first-page":"4201","DOI":"10.1002\/cncr.26028","article-title":"D9S168 microsatellite alteration predicts a poor prognosis in patients with clear cell renal cell carcinoma and correlates with the down-regulation of protein tyrosine phosphatase receptor delta","volume":"117","author":"Li","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.bbadis.2013.05.022_bb1890","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1476-4598-11-6","article-title":"Protein tyrosine phosphatase receptor delta acts as a neuroblastoma tumor suppressor by destabilizing the aurora kinase A oncogene","volume":"11","author":"Meehan","year":"2012","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbadis.2013.05.022_bb1895","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1006\/dbio.1997.8630","article-title":"Impaired mammary gland development and function in mice lacking LAR receptor-like tyrosine phosphatase activity","volume":"188","author":"Schaapveld","year":"1997","journal-title":"Dev. Biol."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1900","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/S0306-4522(00)00526-1","article-title":"A decrease in size and number of basal forebrain cholinergic neurons is paralleled by diminished hippocampal cholinergic innervation in mice lacking leukocyte common antigen-related protein tyrosine phosphatase activity","volume":"102","author":"Van Lieshout","year":"2001","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbadis.2013.05.022_bb1905","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/nn1416","article-title":"LAR receptor protein tyrosine phosphatases in the development and maintenance of excitatory synapses","volume":"8","author":"Dunah","year":"2005","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1910","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.mcn.2006.01.003","article-title":"Downregulation of the LAR protein tyrosine phosphatase receptor is associated with increased dentate gyrus neurogenesis and an increased number of granule cell layer neurons","volume":"31","author":"Bernabeu","year":"2006","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1915","doi-asserted-by":"crossref","first-page":"19808","DOI":"10.1074\/jbc.M610452200","article-title":"Leukocyte antigen-related deficiency enhances insulin-like growth factor-1 signaling in vascular smooth muscle cells and promotes neointima formation in response to vascular injury","volume":"282","author":"Niu","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1920","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1471-2350-12-46","article-title":"PTPRF is disrupted in a patient with syndromic amastia","volume":"12","author":"Ausavarat","year":"2011","journal-title":"BMC Med. Genet."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1925","doi-asserted-by":"crossref","first-page":"9792","DOI":"10.1074\/jbc.275.13.9792","article-title":"Identification of tyrosine phosphatases that dephosphorylate the insulin receptor. A brute force approach based on \u201csubstrate-trapping\u201d mutants","volume":"275","author":"Walchli","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1930","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0898-6568(96)00101-5","article-title":"Suppression of insulin receptor activation by overexpression of the protein-tyrosine phosphatase LAR in hepatoma cells","volume":"8","author":"Li","year":"1996","journal-title":"Cell. Signal."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1935","first-page":"575","article-title":"Modulation of insulin signal transduction by eutopic overexpression of the receptor-type protein-tyrosine phosphatase LAR","volume":"10","author":"Zhang","year":"1996","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1940","doi-asserted-by":"crossref","first-page":"3024","DOI":"10.1016\/j.febslet.2005.04.057","article-title":"Knock-down of LAR protein tyrosine phosphatase induces insulin resistance","volume":"579","author":"Mander","year":"2005","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1945","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0014-5793(97)01133-2","article-title":"Expression of protein-tyrosine phosphatases in the major insulin target tissues","volume":"415","author":"Norris","year":"1997","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1950","doi-asserted-by":"crossref","first-page":"5187","DOI":"10.1073\/pnas.071050398","article-title":"Overexpression of the LAR (leukocyte antigen-related) protein-tyrosine phosphatase in muscle causes insulin resistance","volume":"98","author":"Zabolotny","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1955","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s00109-004-0544-1","article-title":"The allelic variant of LAR gene promoter \u2212127 bp T\u2013>A is associated with reduced risk of obesity and other features related to insulin resistance","volume":"82","author":"Miscio","year":"2004","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1960","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/j.1365-2796.2008.01924.x","article-title":"The protein tyrosine phosphatase receptor type f (PTPRF) locus is associated with coronary artery disease in type 2 diabetes","volume":"263","author":"Menzaghi","year":"2008","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1965","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/ng903","article-title":"Ptprj is a candidate for the mouse colon-cancer susceptibility locus Scc1 and is frequently deleted in human cancers","volume":"31","author":"Ruivenkamp","year":"2002","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1970","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1128\/MCB.23.5.1817-1831.2003","article-title":"A mutant receptor tyrosine phosphatase, CD148, causes defects in vascular development","volume":"23","author":"Takahashi","year":"2003","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1345","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1182\/blood-2005-10-4296","article-title":"A monoclonal antibody against CD148, a receptor-like tyrosine phosphatase, inhibits endothelial-cell growth and angiogenesis","volume":"108","author":"Takahashi","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bbadis.2013.05.022_bb1350","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1089\/dna.2006.25.376","article-title":"Genetic ablation of Ptprj, a mouse cancer susceptibility gene, results in normal growth and development and does not predispose to spontaneous tumorigenesis","volume":"25","author":"Trapasso","year":"2006","journal-title":"DNA Cell Biol."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1355","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1053\/j.gastro.2010.08.063","article-title":"Germline epigenetic silencing of the tumor suppressor gene PTPRJ in early-onset familial colorectal cancer","volume":"139","author":"Venkatachalam","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbadis.2013.05.022_bb1360","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/ng.283","article-title":"Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3\u2032 exons of TACSTD1","volume":"41","author":"Ligtenberg","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1365","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/nature10275","article-title":"A continuum model for tumour suppression","volume":"476","author":"Berger","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2013.05.022_bb1370","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1093\/hmg\/ddi237","article-title":"Allelic association of the human homologue of the mouse modifier Ptprj with breast cancer","volume":"14","author":"Lesueur","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1375","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1677\/ERC-10-0143","article-title":"Role of PTPRJ genotype in papillary thyroid carcinoma risk","volume":"17","author":"Iuliano","year":"2010","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.bbadis.2013.05.022_bb1380","doi-asserted-by":"crossref","first-page":"14997","DOI":"10.1074\/jbc.M901901200","article-title":"Density-enhanced phosphatase 1 regulates phosphorylation of tight junction proteins and enhances barrier function of epithelial cells","volume":"284","author":"Sallee","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1385","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1182\/blood-2012-04-424044","article-title":"Polymorphisms of protein tyrosine phosphatase CD148 influence FcgammaRIIA-dependent platelet activation and the risk of heparin-induced thrombocytopenia","volume":"120","author":"Rollin","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.bbadis.2013.05.022_bb1390","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/j.1600-065X.2008.00752.x","article-title":"CD45, CD148, and Lyp\/Pep: critical phosphatases regulating Src family kinase signaling networks in immune cells","volume":"228","author":"Hermiston","year":"2009","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1395","doi-asserted-by":"crossref","first-page":"4942","DOI":"10.1182\/blood-2008-08-174318","article-title":"The tyrosine phosphatase CD148 is an essential positive regulator of platelet activation and thrombosis","volume":"113","author":"Senis","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bbadis.2013.05.022_bb1400","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1172\/JCI66397","article-title":"The phosphatase CD148 promotes airway hyperresponsiveness through SRC family kinases","volume":"123","author":"Katsumoto","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1405","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.immuni.2011.09.011","article-title":"Receptor-like tyrosine phosphatases CD45 and CD148 have distinct functions in chemoattractant-mediated neutrophil migration and response to S. aureus","volume":"35","author":"Zhu","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.bbadis.2013.05.022_bb1410","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1007\/s00125-011-2221-6","article-title":"Deletion of Ia-2 and\/or Ia-2beta in mice decreases insulin secretion by reducing the number of dense core vesicles","volume":"54","author":"Cai","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbadis.2013.05.022_bb1415","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1042\/bj20021851","article-title":"A novel strategy for the development of selective active-site inhibitors of the protein tyrosine phosphatase-like proteins islet-cell antigen 512 (IA-2) and phogrin (IA-2beta)","volume":"373","author":"Drake","year":"2003","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1420","doi-asserted-by":"crossref","first-page":"10487","DOI":"10.1074\/jbc.M109.066563","article-title":"The neurosecretory vesicle protein phogrin functions as a phosphatidylinositol phosphatase to regulate insulin secretion","volume":"285","author":"Caromile","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1425","doi-asserted-by":"crossref","first-page":"95ra75","DOI":"10.1126\/scitranslmed.3002464","article-title":"Rare copy number variation discovery and cross-disorder comparisons identify risk genes for ADHD","volume":"3","author":"Lionel","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1430","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1038\/npp.2011.122","article-title":"A genomewide linkage scan of cocaine dependence and major depressive episode in two populations","volume":"36","author":"Yang","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbadis.2013.05.022_bb1435","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1006\/geno.1995.1021","article-title":"Molecular cloning of cDNAs encoding human GLEPP1, a membrane protein tyrosine phosphatase: characterization of the GLEPP1 protein distribution in human kidney and assignment of the GLEPP1 gene to human chromosome 12p12\u2013p13","volume":"27","author":"Wiggins","year":"1995","journal-title":"Genomics"},{"key":"10.1016\/j.bbadis.2013.05.022_bb1440","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1172\/JCI7236","article-title":"Altered podocyte structure in GLEPP1 (Ptpro)-deficient mice associated with hypertension and low glomerular filtration rate","volume":"106","author":"Wharram","year":"2000","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1445","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ajhg.2011.05.026","article-title":"Disruption of PTPRO causes childhood-onset nephrotic syndrome","volume":"89","author":"Ozaltin","year":"2011","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1450","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/BF02734151","article-title":"Genetics of idiopathic nephrotic syndrome","volume":"72","author":"Vats","year":"2005","journal-title":"Indian J. Pediatr."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1455","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1128\/MCB.00068-12","article-title":"Expression profiling during mammary epithelial cell three-dimensional morphogenesis identifies PTPRO as a novel regulator of morphogenesis and ErbB2-mediated transformation","volume":"32","author":"Yu","year":"2012","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1460","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1111\/j.1471-4159.2009.06261.x","article-title":"Dimerization of tyrosine phosphatase PTPRO decreases its activity and ability to inactivate TrkC","volume":"110","author":"Hower","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1465","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jpsychires.2011.11.001","article-title":"Genome-wide study identifies PTPRO and WDR72 and FOXQ1-SUMO1P1 interaction associated with neurocognitive function","volume":"46","author":"LeBlanc","year":"2012","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1470","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.mcn.2009.09.009","article-title":"Protein tyrosine phosphatase receptor type O regulates development and function of the sensory nervous system","volume":"42","author":"Gonzalez-Brito","year":"2009","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1475","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1523\/JNEUROSCI.4365-04.2005","article-title":"A novel substrate of receptor tyrosine phosphatase PTPRO is required for nerve growth factor-induced process outgrowth","volume":"25","author":"Chen","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1480","doi-asserted-by":"crossref","first-page":"7563","DOI":"10.1073\/pnas.1336511100","article-title":"Protein tyrosine phosphatase RQ is a phosphatidylinositol phosphatase that can regulate cell survival and proliferation","volume":"100","author":"Oganesian","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1485","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.ajhg.2010.02.015","article-title":"Mutations in PTPRQ are a cause of autosomal-recessive nonsyndromic hearing impairment DFNB84 and associated with vestibular dysfunction","volume":"86","author":"Schraders","year":"2010","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1490","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1136\/jmg.2009.075697","article-title":"Nonsense mutation of the stereociliar membrane protein gene PTPRQ in human hearing loss DFNB84","volume":"47","author":"Shahin","year":"2010","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1495","doi-asserted-by":"crossref","first-page":"9208","DOI":"10.1523\/JNEUROSCI.23-27-09208.2003","article-title":"A receptor-like inositol lipid phosphatase is required for the maturation of developing cochlear hair bundles","volume":"23","author":"Goodyear","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1500","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1523\/JNEUROSCI.3635-11.2012","article-title":"Hair bundle defects and loss of function in the vestibular end organs of mice lacking the receptor-like inositol lipid phosphatase PTPRQ","volume":"32","author":"Goodyear","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1505","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s12311-008-0088-y","article-title":"PTPRR protein tyrosine phosphatase isoforms and locomotion of vesicles and mice","volume":"8","author":"Hendriks","year":"2009","journal-title":"Cerebellum"},{"key":"10.1016\/j.bbadis.2013.05.022_bb1510","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1111\/j.1471-4159.2006.04398.x","article-title":"Altered MAP kinase phosphorylation and impaired motor coordination in PTPRR deficient mice","volume":"101","author":"Chirivi","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1515","doi-asserted-by":"crossref","first-page":"7337","DOI":"10.1093\/emboj\/17.24.7337","article-title":"PTP-SL and STEP protein tyrosine phosphatases regulate the activation of the extracellular signal-regulated kinases ERK1 and ERK2 by association through a kinase interaction motif","volume":"17","author":"Pulido","year":"1998","journal-title":"EMBO J."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1520","doi-asserted-by":"crossref","first-page":"21900","DOI":"10.1074\/jbc.274.31.21900","article-title":"Interaction of mitogen-activated protein kinases with the kinase interaction motif of the tyrosine phosphatase PTP-SL provides substrate specificity and retains ERK2 in the cytoplasm","volume":"274","author":"Z\u00fa\u00f1iga","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1525","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1042\/bj20021941","article-title":"Differential interaction of the tyrosine phosphatases PTP-SL, STEP and HePTP with the mitogen-activated protein kinases ERK1\/2 and p38alpha is determined by a kinase specificity sequence and influenced by reducing agents","volume":"372","author":"Mu\u00f1oz","year":"2003","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1530","doi-asserted-by":"crossref","first-page":"29503","DOI":"10.1074\/jbc.M202149200","article-title":"Phosphotyrosine-specific phosphatase PTP-SL regulates the ERK5 signaling pathway","volume":"277","author":"Buschbeck","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1535","doi-asserted-by":"crossref","first-page":"7311","DOI":"10.1523\/JNEUROSCI.23-19-07311.2003","article-title":"The role of the extracellular signal-regulated kinase signaling pathway in mood modulation","volume":"23","author":"Einat","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1540","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/01.yco.0000218604.63463.cd","article-title":"The extracellular signal-regulated kinase pathway: an emerging promising target for mood stabilizers","volume":"19","author":"Chen","year":"2006","journal-title":"Curr. Opin. Psychiatry"},{"key":"10.1016\/j.bbadis.2013.05.022_bb1545","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1038\/nm.2219","article-title":"A negative regulator of MAP kinase causes depressive behavior","volume":"16","author":"Duric","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1550","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/6859","article-title":"Neuroendocrine dysplasia in mice lacking protein tyrosine phosphatase sigma","volume":"21","author":"Elchebly","year":"1999","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1555","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.cub.2007.06.013","article-title":"Protein-tyrosine phosphatase sigma is associated with ulcerative colitis","volume":"17","author":"Muise","year":"2007","journal-title":"Curr. Biol."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1560","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1016\/j.cellsig.2010.06.001","article-title":"Receptor tyrosine phosphatase sigma (RPTPsigma) regulates, p250GAP, a novel substrate that attenuates Rac signaling","volume":"22","author":"Chagnon","year":"2010","journal-title":"Cell. Signal."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1565","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S1044-7431(03)00120-9","article-title":"Receptor protein tyrosine phosphatase sigma inhibits axonal regeneration and the rate of axon extension","volume":"23","author":"Thompson","year":"2003","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1570","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.mcn.2004.10.011","article-title":"Receptor protein tyrosine phosphatase sigma inhibits axon regrowth in the adult injured CNS","volume":"28","author":"Sapieha","year":"2005","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1575","first-page":"924","article-title":"Maturation of ureter\u2013bladder connection in mice is controlled by LAR family receptor protein tyrosine phosphatases","volume":"119","author":"Uetani","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1580","doi-asserted-by":"crossref","first-page":"19024","DOI":"10.1073\/pnas.1111963108","article-title":"Genomic dissection of the epidermal growth factor receptor (EGFR)\/PI3K pathway reveals frequent deletion of the EGFR phosphatase PTPRS in head and neck cancers","volume":"108","author":"Morris","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1585","doi-asserted-by":"crossref","first-page":"4069","DOI":"10.1038\/sj.onc.1202794","article-title":"The transmembrane protein tyrosine phosphatase RPTPsigma modulates signaling of the epidermal growth factor receptor in A431 cells","volume":"18","author":"Suarez Pestana","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.bbadis.2013.05.022_bb1590","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1139\/y06-020","article-title":"Altered glucose homeostasis in mice lacking the receptor protein tyrosine phosphatase sigma","volume":"84","author":"Chagnon","year":"2006","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1595","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1530\/EJE-07-0114","article-title":"Genetic variation in receptor protein tyrosine phosphatase sigma is associated with type 2 diabetes in Swedish Caucasians","volume":"157","author":"Langberg","year":"2007","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1600","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1385\/JMN:29:3:241","article-title":"Receptor protein tyrosine phosphatase from stem cells to mature glial cells of the central nervous system","volume":"29","author":"Lamprianou","year":"2006","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1605","doi-asserted-by":"crossref","first-page":"7706","DOI":"10.1128\/MCB.20.20.7706-7715.2000","article-title":"No obvious abnormality in mice deficient in receptor protein tyrosine phosphatase beta","volume":"20","author":"Harroch","year":"2000","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1610","doi-asserted-by":"crossref","first-page":"259","DOI":"10.4049\/jimmunol.1101468","article-title":"The cytokine midkine and its receptor RPTPzeta regulate B cell survival in a pathway induced by CD74","volume":"188","author":"Cohen","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1615","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1523\/JNEUROSCI.2565.04.2005","article-title":"Age-dependent enhancement of hippocampal long-term potentiation and impairment of spatial learning through the Rho-associated kinase pathway in protein tyrosine phosphatase receptor type Z-deficient mice","volume":"25","author":"Niisato","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1620","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/ng1004","article-title":"A critical role for the protein tyrosine phosphatase receptor type Z in functional recovery from demyelinating lesions","volume":"32","author":"Harroch","year":"2002","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1625","doi-asserted-by":"crossref","first-page":"e48797","DOI":"10.1371\/journal.pone.0048797","article-title":"Protein tyrosine phosphatase receptor type z negatively regulates oligodendrocyte differentiation and myelination","volume":"7","author":"Kuboyama","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2013.05.022_bb1630","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1016\/j.ajpath.2012.07.011","article-title":"Accelerated axonal loss following acute CNS demyelination in mice lacking protein tyrosine phosphatase receptor type z","volume":"181","author":"Huang","year":"2012","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1635","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/ng1112","article-title":"Mice deficient in protein tyrosine phosphatase receptor type Z are resistant to gastric ulcer induction by VacA of Helicobacter pylori","volume":"33","author":"Fujikawa","year":"2003","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1640","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/sj.mp.4001991","article-title":"Molecular dissection of NRG1-ERBB4 signaling implicates PTPRZ1 as a potential schizophrenia susceptibility gene","volume":"13","author":"Buxbaum","year":"2008","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bbadis.2013.05.022_bb1645","first-page":"295-295","article-title":"Identification of PTPRZ1 as a schizophrenia susceptibility gene","volume":"33","author":"Buxbaum","year":"2007","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1650","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1038\/tp.2011.8","article-title":"Increased expression of receptor phosphotyrosine phosphatase-z is associated with molecular, cellular, behavioral and cognitive schizophrenia phenotypes","volume":"1","author":"Takahashi","year":"2011","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.bbadis.2013.05.022_bb1655","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1002\/ajmg.b.30692","article-title":"No association between the protein tyrosine phosphatase, receptor-type, Z Polypeptide 1 (PTPRZ1) gene and schizophrenia in the Japanese population","volume":"147B","author":"Ito","year":"2008","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1660","first-page":"187-187","article-title":"Rptpz\/Phosphacan abnormalities in the amygdala of subjects diagnosed with schizophrenia","volume":"37","author":"Berretta","year":"2011","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1665","doi-asserted-by":"crossref","first-page":"37137","DOI":"10.1074\/jbc.M111.270140","article-title":"Consensus substrate sequence for protein-tyrosine phosphatase receptor type Z","volume":"286","author":"Fujikawa","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1670","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s12079-012-0171-5","article-title":"Receptor type protein tyrosine phosphatases (RPTPs)\u2014roles in signal transduction and human disease","volume":"6","author":"Xu","year":"2012","journal-title":"J. Cell Commun. Signal."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1675","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1038\/sj.onc.1210412","article-title":"Differential regulation of MAP kinase signalling by dual-specificity protein phosphatases","volume":"26","author":"Owens","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.bbadis.2013.05.022_bb1680","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.bbamcr.2006.12.002","article-title":"Regulation of MAP kinases by MAP kinase phosphatases","volume":"1773","author":"Kondoh","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2013.05.022_bb1685","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.lfs.2011.11.017","article-title":"Mitogen-activated protein kinase phosphatase (MKP)-1 in immunology, physiology, and disease","volume":"90","author":"Wancket","year":"2012","journal-title":"Life Sci."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1690","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1189\/jlb.1006639","article-title":"Regulation of innate immunity by MAPK dual-specificity phosphatases: knockout models reveal new tricks of old genes","volume":"81","author":"Salojin","year":"2007","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1695","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.jaci.2010.06.007","article-title":"Dual-specificity phosphatase 1 as a pharmacogenetic modifier of inhaled steroid response among asthmatic patients","volume":"126","author":"Jin","year":"2010","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1700","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1165\/rcmb.2007-0014OC","article-title":"Corticosteroids reduce IL-6 in ASM cells via up-regulation of MKP-1","volume":"39","author":"Quante","year":"2008","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1705","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.cellsig.2011.12.013","article-title":"MKP-1: a negative feedback effector that represses MAPK-mediated pro-inflammatory signaling pathways and cytokine secretion in human airway smooth muscle cells","volume":"24","author":"Manetsch","year":"2012","journal-title":"Cell. Signal."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1710","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.bbamcr.2009.12.007","article-title":"Proteasomal inhibition upregulates the endogenous MAPK deactivator MKP-1 in human airway smooth muscle: mechanism of action and effect on cytokine secretion","volume":"1803","author":"Moutzouris","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"issue":"2","key":"10.1016\/j.bbadis.2013.05.022_bb1715","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1742-4658.2012.08716.x","article-title":"Dual-specificity MAP kinase phosphatases (MKPs): shaping the outcome of MAP kinase signalling","volume":"280","author":"Caunt","year":"2013","journal-title":"FEBS J."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1720","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1242\/dev.02701","article-title":"Dusp6 (Mkp3) is a negative feedback regulator of FGF-stimulated ERK signaling during mouse development","volume":"134","author":"Li","year":"2007","journal-title":"Development"},{"key":"10.1016\/j.bbadis.2013.05.022_bb1725","doi-asserted-by":"crossref","first-page":"31246","DOI":"10.1074\/jbc.M806085200","article-title":"DUSP6 (MKP3) null mice show enhanced ERK1\/2 phosphorylation at baseline and increased myocyte proliferation in the heart affecting disease susceptibility","volume":"283","author":"Maillet","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1730","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/sj.mp.4001807","article-title":"The association of DUSP6 gene with schizophrenia and bipolar disorder: its possible role in the development of bipolar disorder","volume":"11","author":"Lee","year":"2006","journal-title":"Mol. Psychiatry"},{"issue":"1","key":"10.1016\/j.bbadis.2013.05.022_bb1735","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.pnpbp.2011.11.014","article-title":"The genetic association of DUSP6 with bipolar disorder and its effect on ERK activity","volume":"37","author":"Kim","year":"2012","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.bbadis.2013.05.022_bb1740","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1016\/j.neubiorev.2012.07.008","article-title":"Potential opposite roles of the extracellular signal-regulated kinase (ERK) pathway in autism spectrum and bipolar disorders","volume":"36","author":"Kalkman","year":"2012","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1975","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/ng.609","article-title":"Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis","volume":"42","author":"Voight","year":"2010","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1745","doi-asserted-by":"crossref","first-page":"e46263","DOI":"10.1371\/journal.pone.0046263","article-title":"A single nucleotide polymorphism within DUSP9 is associated with susceptibility to type 2 diabetes in a Japanese population","volume":"7","author":"Fukuda","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2013.05.022_bb1750","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1177\/1947601911407325","article-title":"PTEN tumor suppressor network in PI3K-Akt pathway control","volume":"1","author":"Georgescu","year":"2011","journal-title":"Genes Cancer"},{"key":"10.1016\/j.bbadis.2013.05.022_bb1755","doi-asserted-by":"crossref","first-page":"4325","DOI":"10.1158\/1078-0432.CCR-09-2990","article-title":"PI(3)king apart PTEN's role in cancer","volume":"16","author":"Zhang","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1760","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.tips.2010.12.005","article-title":"Non-genomic loss of PTEN function in cancer: not in my genes","volume":"32","author":"Leslie","year":"2010","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1765","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/nrm3330","article-title":"The functions and regulation of the PTEN tumour suppressor","volume":"13","author":"Song","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1770","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.advenzreg.2008.12.002","article-title":"The significance of PTEN's protein phosphatase activity","volume":"49","author":"Leslie","year":"2009","journal-title":"Adv. Enzyme Regul."},{"issue":"3","key":"10.1016\/j.bbadis.2013.05.022_bb1775","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1042\/BJ20120098","article-title":"Functional analysis of the protein phosphatase activity of PTEN","volume":"444","author":"Zhang","year":"2012","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1780","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1158\/0008-5472.CAN-10-3399","article-title":"CREB is a novel nuclear target of PTEN phosphatase","volume":"71","author":"Gu","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1785","doi-asserted-by":"crossref","first-page":"E2179","DOI":"10.1210\/jc.2012-1991","article-title":"PTEN lipid phosphatase activity and proper subcellular localization are necessary and sufficient for down-regulating AKT phosphorylation in the nucleus in Cowden Syndrome","volume":"97","author":"He","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1790","doi-asserted-by":"crossref","first-page":"5387","DOI":"10.1038\/onc.2008.237","article-title":"Genetic and phenotypic heterogeneity in the PTEN hamartoma tumour syndrome","volume":"27","author":"Orloff","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.bbadis.2013.05.022_bb1795","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/nrc3037","article-title":"PTEN loss in the continuum of common cancers, rare syndromes and mouse models","volume":"11","author":"Hollander","year":"2011","journal-title":"Nat. Rev."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1800","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1097\/GIM.0b013e3181ac9aea","article-title":"PTEN hamartoma tumor syndrome: an overview","volume":"11","author":"Hobert","year":"2009","journal-title":"Genet. Med."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1805","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1038\/ejhg.2008.162","article-title":"PTEN hamartoma tumor syndromes","volume":"16","author":"Blumenthal","year":"2008","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.bbadis.2013.05.022_bb1810","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ajhg.2010.11.013","article-title":"A clinical scoring system for selection of patients for PTEN mutation testing is proposed on the basis of a prospective study of 3042 probands","volume":"88","author":"Tan","year":"2011","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0005","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1056\/NEJMoa1113966","article-title":"PTEN mutations as a cause of constitutive insulin sensitivity and obesity","volume":"367","author":"Pal","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0010","doi-asserted-by":"crossref","first-page":"4132","DOI":"10.1093\/hmg\/ddr337","article-title":"A comprehensive functional analysis of PTEN mutations: implications in tumor- and autism-related syndromes","volume":"20","author":"Rodriguez-Escudero","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0015","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/S0960-9822(07)00488-5","article-title":"High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice","volume":"8","author":"Suzuki","year":"1998","journal-title":"Curr. Biol."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0020","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1247\/csf.28.11","article-title":"Physiological functions of Pten in mouse tissues","volume":"28","author":"Kishimoto","year":"2003","journal-title":"Cell Struct. Funct."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0025","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/nrc3057","article-title":"Pro-senescence therapy for cancer treatment","volume":"11","author":"Nardella","year":"2011","journal-title":"Nat. Rev."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0030","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1158\/0008-5472.CAN-06-3524","article-title":"Pten loss in the mouse thyroid causes goiter and follicular adenomas: insights into thyroid function and Cowden disease pathogenesis","volume":"67","author":"Yeager","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0035","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.neuron.2006.03.023","article-title":"Pten regulates neuronal arborization and social interaction in mice","volume":"50","author":"Kwon","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.bbadis.2013.05.022_bb0040","doi-asserted-by":"crossref","first-page":"5416","DOI":"10.1038\/onc.2008.239","article-title":"PTEN signaling in brain: neuropathology and tumorigenesis","volume":"27","author":"Endersby","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.bbadis.2013.05.022_bb0045","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/ejhg.2011.20","article-title":"Analysis of prevalence and degree of macrocephaly in patients with germline PTEN mutations and of brain weight in Pten knock-in murine model","volume":"19","author":"Mester","year":"2011","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0050","first-page":"3605","article-title":"High incidence of breast and endometrial neoplasia resembling human Cowden syndrome in pten+\/\u2212 mice","volume":"60","author":"Stambolic","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0055","doi-asserted-by":"crossref","first-page":"9731","DOI":"10.1158\/0008-5472.CAN-07-1278","article-title":"In vivo functional analysis of the counterbalance of hyperactive phosphatidylinositol 3-kinase p110 catalytic oncoproteins by the tumor suppressor PTEN","volume":"67","author":"Andres-Pons","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0060","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1158\/0008-5472.CAN-10-2488","article-title":"PTEN level in tumor suppression: how much is too little?","volume":"71","author":"Carracedo","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0065","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.cell.2012.02.030","article-title":"Systemic elevation of PTEN induces a tumor-suppressive metabolic state","volume":"149","author":"Garcia-Cao","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2013.05.022_bb0070","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.cmet.2012.02.001","article-title":"Pten positively regulates brown adipose function, energy expenditure, and longevity","volume":"15","author":"Ortega-Molina","year":"2012","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0075","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1089\/dna.2010.1126","article-title":"Association of PTEN polymorphisms with susceptibility to hepatocellular carcinoma in a Han Chinese population","volume":"30","author":"Ding","year":"2011","journal-title":"DNA Cell Biol."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0080","doi-asserted-by":"crossref","first-page":"R130","DOI":"10.1186\/bcr3076","article-title":"Variants on the promoter region of PTEN affect breast cancer progression and patient survival","volume":"13","author":"Heikkinen","year":"2011","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0085","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/jhg.2012.15","article-title":"Association of genetic polymorphisms in MDM2, PTEN and P53 with risk of esophageal squamous cell carcinoma","volume":"57","author":"Ma","year":"2012","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1517\/14728222.2013.727398","article-title":"Association between PTEN IVS4 polymorphism and development of colorectal cancer in a Turkish population","volume":"17","author":"Canbay","year":"2013","journal-title":"Expert Opin. Ther. Targets"},{"issue":"2","key":"10.1016\/j.bbadis.2013.05.022_bb0095","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1007\/s11033-012-2235-2","article-title":"HER2 Ile655Val and PTEN IVS4 polymorphisms in patients with breast cancer","volume":"40","author":"Ozturk","year":"2013","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0100","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1016\/j.rmed.2009.06.016","article-title":"PTEN identified as important risk factor of chronic obstructive pulmonary disease","volume":"103","author":"Hosgood","year":"2009","journal-title":"Respir. Med."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0105","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/j.jocn.2011.11.042","article-title":"Association of PTEN genetic polymorphisms with atherosclerotic cerebral infarction in the Han Chinese population","volume":"19","author":"Yuan","year":"2012","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0110","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s10555-008-9121-3","article-title":"PRL PTPs: mediators and markers of cancer progression","volume":"27","author":"Bessette","year":"2008","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0115","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2174\/187152011794941145","article-title":"PRL-3, an emerging marker of carcinogenesis, is strongly associated with poor prognosis","volume":"11","author":"Guzinska-Ustymowicz","year":"2011","journal-title":"Anticancer Agents Med. Chem."},{"issue":"2","key":"10.1016\/j.bbadis.2013.05.022_bb0120","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1742-4658.2012.08565.x","article-title":"Molecular mechanisms of the PRL phosphatases","volume":"280","author":"Rios","year":"2013","journal-title":"FEBS J."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0125","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1158\/0008-5472.CAN-05-3116","article-title":"PRL tyrosine phosphatases regulate rho family GTPases to promote invasion and motility","volume":"66","author":"Fiordalisi","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0130","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1158\/0008-5472.CAN-06-2436","article-title":"PRL-1 tyrosine phosphatase regulates c-Src levels, adherence, and invasion in human lung cancer cells","volume":"67","author":"Achiwa","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0135","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0304-3835(03)00517-2","article-title":"Enhanced cell cycle progression and down regulation of p21(Cip1\/Waf1) by PRL tyrosine phosphatases","volume":"202","author":"Werner","year":"2003","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0140","doi-asserted-by":"crossref","first-page":"e26726","DOI":"10.1371\/journal.pone.0026726","article-title":"A novel, functional and replicable risk gene region for alcohol dependence identified by genome-wide association study","volume":"6","author":"Zuo","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2013.05.022_bb0145","doi-asserted-by":"crossref","first-page":"6368","DOI":"10.1073\/pnas.0510188103","article-title":"Toward understanding the genetics of alcohol drinking through transcriptome meta-analysis","volume":"103","author":"Mulligan","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0150","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1242\/jcs.03040","article-title":"Systematic analysis of myotubularins: heteromeric interactions, subcellular localisation and endosome related functions","volume":"119","author":"Lorenzo","year":"2006","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0155","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.molmed.2012.04.004","article-title":"Myotubularin phosphoinositide phosphatases: cellular functions and disease pathophysiology","volume":"18","author":"Hnia","year":"2012","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0160","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1042\/BJ20101267","article-title":"The myotubularin family of lipid phosphatases in disease and in spermatogenesis","volume":"433","author":"Mruk","year":"2011","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0165","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.tcb.2006.06.001","article-title":"Myotubularin phosphatases: policing 3-phosphoinositides","volume":"16","author":"Robinson","year":"2006","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0170","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1582-4934.2009.00967.x","article-title":"The CMT4B disease-causing proteins MTMR2 and MTMR13\/SBF2 regulate AKT signaling","volume":"15","author":"Berger","year":"2009","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0175","doi-asserted-by":"crossref","first-page":"20005","DOI":"10.1074\/jbc.M110.197749","article-title":"Myotubularin regulates Akt-dependent survival signaling via phosphatidylinositol 3-phosphate","volume":"286","author":"Razidlo","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0180","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s00439-002-0869-1","article-title":"Characterisation of mutations in 77 patients with X-linked myotubular myopathy, including a family with a very mild phenotype","volume":"112","author":"Biancalana","year":"2003","journal-title":"Hum. Genet."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0185","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/humu.10033","article-title":"Characterization of mutations in fifty North American patients with X-linked myotubular myopathy","volume":"19","author":"Herman","year":"2002","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0190","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/(SICI)1098-1004(200005)15:5<393::AID-HUMU1>3.0.CO;2-R","article-title":"MTM1 mutations in X-linked myotubular myopathy","volume":"15","author":"Laporte","year":"2000","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0195","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/ng0696-175","article-title":"A gene mutated in X-linked myotubular myopathy defines a new putative tyrosine phosphatase family conserved in yeast","volume":"13","author":"Laporte","year":"1996","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0200","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.nmd.2010.01.014","article-title":"Centronuclear myopathies: a widening concept","volume":"20","author":"Romero","year":"2010","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0205","doi-asserted-by":"crossref","first-page":"18763","DOI":"10.1073\/pnas.0900705106","article-title":"T-tubule disorganization and defective excitation-contraction coupling in muscle fibers lacking myotubularin lipid phosphatase","volume":"106","author":"Al-Qusairi","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0210","doi-asserted-by":"crossref","first-page":"15060","DOI":"10.1073\/pnas.212498399","article-title":"The lipid phosphatase myotubularin is essential for skeletal muscle maintenance but not for myogenesis in mice","volume":"99","author":"Buj-Bello","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0215","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1093\/hmg\/ddr512","article-title":"Modeling the human MTM1 p.R69C mutation in murine Mtm1 results in exon 4 skipping and a less severe myotubular myopathy phenotype","volume":"21","author":"Pierson","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0220","doi-asserted-by":"crossref","first-page":"14697","DOI":"10.1073\/pnas.1003677107","article-title":"MTM1 mutation associated with X-linked myotubular myopathy in Labrador Retrievers","volume":"107","author":"Beggs","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0225","doi-asserted-by":"crossref","first-page":"e1000372","DOI":"10.1371\/journal.pgen.1000372","article-title":"Loss of myotubularin function results in T-tubule disorganization in zebrafish and human myotubular myopathy","volume":"5","author":"Dowling","year":"2009","journal-title":"PLoS Genet."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0230","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1172\/JCI44021","article-title":"Myotubularin controls desmin intermediate filament architecture and mitochondrial dynamics in human and mouse skeletal muscle","volume":"121","author":"Hnia","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0235","doi-asserted-by":"crossref","first-page":"e1002965","DOI":"10.1371\/journal.pgen.1002965","article-title":"Phosphatase-dead myotubularin ameliorates X-linked centronuclear myopathy phenotypes in mice","volume":"8","author":"Amoasii","year":"2012","journal-title":"PLoS Genet."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0240","doi-asserted-by":"crossref","first-page":"819","DOI":"10.4161\/auto.6.6.12624","article-title":"The role of MTMR14 in autophagy and in muscle disease","volume":"6","author":"Gibbs","year":"2010","journal-title":"Autophagy"},{"key":"10.1016\/j.bbadis.2013.05.022_bb0245","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.1093\/hmg\/ddl250","article-title":"A novel PtdIns3P and PtdIns(3,5)P2 phosphatase with an inactivating variant in centronuclear myopathy","volume":"15","author":"Tosch","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0250","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.febslet.2010.02.054","article-title":"The role of PI3P phosphatases in the regulation of autophagy","volume":"584","author":"Vergne","year":"2010","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0255","doi-asserted-by":"crossref","first-page":"504","DOI":"10.18632\/aging.100190","article-title":"Muscle-specific inositide phosphatase (MIP\/MTMR14) is reduced with age and its loss accelerates skeletal muscle aging process by altering calcium homeostasis","volume":"2","author":"Romero-Suarez","year":"2010","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.bbadis.2013.05.022_bb0260","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/ncb1884","article-title":"Deficiency of MIP\/MTMR14 phosphatase induces a muscle disorder by disrupting Ca(2+) homeostasis","volume":"11","author":"Shen","year":"2009","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0265","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1093\/hmg\/ddq153","article-title":"Zebrafish MTMR14 is required for excitation-contraction coupling, developmental motor function and the regulation of autophagy","volume":"19","author":"Dowling","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0270","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/00131402-200312000-00002","article-title":"Hereditary neuropathies","volume":"5","author":"Jaradeh","year":"2003","journal-title":"J. Clin. Neuromuscul. Dis."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5414\/NPP27001","article-title":"Charcot\u2013Marie\u2013Tooth disorders with an autosomal recessive mode of inheritance","volume":"27","author":"Kabzinska","year":"2008","journal-title":"Clin. Neuropathol."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0280","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1093\/hmg\/ddg179","article-title":"Myotubularin-related 2 protein phosphatase and neurofilament light chain protein, both mutated in CMT neuropathies, interact in peripheral nerve","volume":"12","author":"Previtali","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0285","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s12035-007-0031-0","article-title":"Myotubularin-related (MTMR) phospholipid phosphatase proteins in the peripheral nervous system","volume":"35","author":"Bolis","year":"2007","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0290","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/75542","article-title":"Charcot\u2013Marie\u2013Tooth type 4B is caused by mutations in the gene encoding myotubularin-related protein-2","volume":"25","author":"Bolino","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0295","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/hmg\/ddg030","article-title":"Mutation of the SBF2 gene, encoding a novel member of the myotubularin family, in Charcot\u2013Marie\u2013Tooth neuropathy type 4B2\/11p15","volume":"12","author":"Senderek","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0300","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1093\/hmg\/11.13.1569","article-title":"Loss of phosphatase activity in myotubularin-related protein 2 is associated with Charcot\u2013Marie\u2013Tooth disease type 4B1","volume":"11","author":"Berger","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0305","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.1093\/hmg\/ddm257","article-title":"Mtmr13\/Sbf2-deficient mice: an animal model for CMT4B2","volume":"16","author":"Tersar","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0310","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.1093\/hmg\/ddi400","article-title":"An animal model for Charcot\u2013Marie\u2013Tooth disease type 4B1","volume":"14","author":"Bonneick","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0315","doi-asserted-by":"crossref","first-page":"8567","DOI":"10.1523\/JNEUROSCI.2493-05.2005","article-title":"Loss of Mtmr2 phosphatase in Schwann cells but not in motor neurons causes Charcot\u2013Marie\u2013Tooth type 4B1 neuropathy with myelin outfoldings","volume":"25","author":"Bolis","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0320","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1083\/jcb.200407010","article-title":"Disruption of Mtmr2 produces CMT4B1-like neuropathy with myelin outfolding and impaired spermatogenesis","volume":"167","author":"Bolino","year":"2004","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0325","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1093\/hmg\/ddn405","article-title":"Genome-wide association study identifies two novel loci containing FLNB and SBF2 genes underlying stature variation","volume":"18","author":"Lei","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0330","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/ng.875","article-title":"A genome-wide association study identifies two new lung cancer susceptibility loci at 13q12.12 and 22q12.2 in Han Chinese","volume":"43","author":"Hu","year":"2011","journal-title":"Nat. Genet."},{"issue":"12","key":"10.1016\/j.bbadis.2013.05.022_bb1980","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1093\/carcin\/bgs292","article-title":"Genetic polymorphism at miR-181a binding site contributes to gastric cancer susceptibility","volume":"33","author":"Lin","year":"2012","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bbadis.2013.05.022_bb0340","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/ibd.21283","article-title":"Genetics of childhood-onset inflammatory bowel disease","volume":"17","author":"Henderson","year":"2011","journal-title":"Inflamm. Bowel Dis."},{"issue":"7","key":"10.1016\/j.bbadis.2013.05.022_bb1985","doi-asserted-by":"crossref","first-page":"1487.e21-8","DOI":"10.1016\/j.neurobiolaging.2011.10.011","article-title":"Genome-wide study links MTMR7 gene to variant Creutzfeldt\u2013Jakob risk","volume":"33","author":"Sanchez-Juan","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbadis.2013.05.022_bb0350","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/jhg.2011.74","article-title":"Association of variations in the FTO, SCG3 and MTMR9 genes with metabolic syndrome in a Japanese population","volume":"56","author":"Hotta","year":"2011","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0355","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1093\/hmg\/ddm260","article-title":"Association of single-nucleotide polymorphisms in MTMR9 gene with obesity","volume":"16","author":"Yanagiya","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0360","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.tibs.2009.08.002","article-title":"Lafora disease: insights into neurodegeneration from plant metabolism","volume":"34","author":"Gentry","year":"2009","journal-title":"Trends Biochem. Sci."},{"issue":"Suppl. 5","key":"10.1016\/j.bbadis.2013.05.022_bb0365","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1528-1167.2009.02117.x","article-title":"The autosomal recessively inherited progressive myoclonus epilepsies and their genes","volume":"50","author":"Ramachandran","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.bbadis.2013.05.022_bb0370","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/iub.1072","article-title":"Deciphering the role of malin in the lafora progressive myoclonus epilepsy","volume":"64","author":"Roma-Mateo","year":"2012","journal-title":"IUBMB Life"},{"key":"10.1016\/j.bbadis.2013.05.022_bb0375","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/humu.20954","article-title":"Lafora progressive myoclonus epilepsy: a meta-analysis of reported mutations in the first decade following the discovery of the EPM2A and NHLRC1 genes","volume":"30","author":"Singh","year":"2009","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0380","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/hmg\/8.2.345","article-title":"A novel protein tyrosine phosphatase gene is mutated in progressive myoclonus epilepsy of the Lafora type (EPM2)","volume":"8","author":"Serratosa","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0385","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/2470","article-title":"Mutations in a gene encoding a novel protein tyrosine phosphatase cause progressive myoclonus epilepsy","volume":"20","author":"Minassian","year":"1998","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0390","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/ng1238","article-title":"Mutations in NHLRC1 cause progressive myoclonus epilepsy","volume":"35","author":"Chan","year":"2003","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0395","doi-asserted-by":"crossref","first-page":"22657","DOI":"10.1074\/jbc.M109.009688","article-title":"Hyperphosphorylation and aggregation of Tau in laforin-deficient mice, an animal model for Lafora disease","volume":"284","author":"Puri","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0400","doi-asserted-by":"crossref","first-page":"19262","DOI":"10.1073\/pnas.0707952104","article-title":"Laforin is a glycogen phosphatase, deficiency of which leads to elevated phosphorylation of glycogen in vivo","volume":"104","author":"Tagliabracci","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.bbadis.2013.05.022_bb1990","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1742-4658.2012.08549.x","article-title":"Laforin, a protein with many faces: glucan phosphatase, adapter protein, and others","volume":"280","author":"Gentry","year":"2013","journal-title":"FEBS J."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0410","doi-asserted-by":"crossref","first-page":"991","DOI":"10.4161\/auto.6.7.13308","article-title":"Impaired autophagy in Lafora disease","volume":"6","author":"Knecht","year":"2010","journal-title":"Autophagy"},{"key":"10.1016\/j.bbadis.2013.05.022_bb0415","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1093\/hmg\/ddq190","article-title":"Laforin, the most common protein mutated in Lafora disease, regulates autophagy","volume":"19","author":"Aguado","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0420","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1093\/hmg\/ddr157","article-title":"Laforin, a dual specificity phosphatase involved in Lafora disease, regulates insulin response and whole-body energy balance in mice","volume":"20","author":"Vernia","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0425","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1093\/hmg\/ddr598","article-title":"Laforin and malin knockout mice have normal glucose disposal and insulin sensitivity","volume":"21","author":"DePaoli-Roach","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0430","doi-asserted-by":"crossref","first-page":"4039","DOI":"10.1158\/0008-5472.CAN-07-6314","article-title":"Laforin confers cancer resistance to energy deprivation-induced apoptosis","volume":"68","author":"Wang","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0435","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ccr.2006.08.008","article-title":"Epm2a suppresses tumor growth in an immunocompromised host by inhibiting Wnt signaling","volume":"10","author":"Wang","year":"2006","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbadis.2013.05.022_bb0440","doi-asserted-by":"crossref","first-page":"7236","DOI":"10.1128\/MCB.01334-08","article-title":"Laforin negatively regulates cell cycle progression through glycogen synthase kinase 3beta-dependent mechanisms","volume":"28","author":"Liu","year":"2008","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0445","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1093\/hmg\/11.11.1251","article-title":"Targeted disruption of the Epm2a gene causes formation of Lafora inclusion bodies, neurodegeneration, ataxia, myoclonus epilepsy and impaired behavioral response in mice","volume":"11","author":"Ganesh","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0450","doi-asserted-by":"crossref","first-page":"33816","DOI":"10.1074\/jbc.M807428200","article-title":"Abnormal metabolism of glycogen phosphate as a cause for Lafora disease","volume":"283","author":"Tagliabracci","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0455","doi-asserted-by":"crossref","first-page":"e5907","DOI":"10.1371\/journal.pone.0005907","article-title":"Increased endoplasmic reticulum stress and decreased proteasomal function in lafora disease models lacking the phosphatase laforin","volume":"4","author":"Vernia","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2013.05.022_bb0460","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/sj.ejhg.5200571","article-title":"Mutational spectrum of the EPM2A gene in progressive myoclonus epilepsy of Lafora: high degree of allelic heterogeneity and prevalence of deletions","volume":"8","author":"Gomez-Garre","year":"2000","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0465","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1111\/j.1528-1167.2007.01004.x","article-title":"Founder effect with variable age at onset in Arab families with Lafora disease and EPM2A mutation","volume":"48","author":"Gomez-Abad","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.bbadis.2013.05.022_bb0470","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1093\/hmg\/ddn199","article-title":"Modulation of functional properties of laforin phosphatase by alternative splicing reveals a novel mechanism for the EPM2A gene in Lafora progressive myoclonus epilepsy","volume":"17","author":"Dubey","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0475","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ygeno.2011.10.001","article-title":"Identification and characterization of novel splice variants of the human EPM2A gene mutated in Lafora progressive myoclonus epilepsy","volume":"99","author":"Dubey","year":"2012","journal-title":"Genomics"},{"key":"10.1016\/j.bbadis.2013.05.022_bb0480","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1006\/mcpr.2001.0371","article-title":"Mutation screening for Japanese Lafora's disease patients: identification of novel sequence variants in the coding and upstream regulatory regions of EPM2A gene","volume":"15","author":"Ganesh","year":"2001","journal-title":"Mol. Cell. Probes"},{"key":"10.1016\/j.bbadis.2013.05.022_bb0485","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1146\/annurev.biochem.76.052705.164916","article-title":"The eyes absent family of phosphotyrosine phosphatases: properties and roles in developmental regulation of transcription","volume":"76","author":"Jemc","year":"2007","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0490","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/nature08138","article-title":"Regulation of the innate immune response by threonine-phosphatase of eyes absent","volume":"460","author":"Okabe","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2013.05.022_bb0495","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1158\/0008-5472.925.65.3","article-title":"Transcriptional coactivator Drosophila eyes absent homologue 2 is up-regulated in epithelial ovarian cancer and promotes tumor growth","volume":"65","author":"Zhang","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0500","doi-asserted-by":"crossref","first-page":"3715","DOI":"10.1038\/onc.2010.122","article-title":"The Eyes Absent phosphatase-transactivator proteins promote proliferation, transformation, migration, and invasion of tumor cells","volume":"29","author":"Pandey","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.bbadis.2013.05.022_bb0505","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/onc.2011.259","article-title":"Eya2 is required to mediate the pro-metastatic functions of Six1 via the induction of TGF-beta signaling, epithelial-mesenchymal transition, and cancer stem cell properties","volume":"31","author":"Farabaugh","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.bbadis.2013.05.022_bb0510","doi-asserted-by":"crossref","first-page":"e34806","DOI":"10.1371\/journal.pone.0034806","article-title":"The EYA tyrosine phosphatase activity is pro-angiogenic and is inhibited by benzbromarone","volume":"7","author":"Tadjuidje","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2013.05.022_bb0515","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nature07849","article-title":"Tyrosine dephosphorylation of H2AX modulates apoptosis and survival decisions","volume":"458","author":"Cook","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2013.05.022_bb0520","doi-asserted-by":"crossref","first-page":"16066","DOI":"10.1074\/jbc.C900032200","article-title":"Dephosphorylation of the C-terminal tyrosyl residue of the DNA damage-related histone H2A.X is mediated by the protein phosphatase eyes absent","volume":"284","author":"Krishnan","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0525","doi-asserted-by":"crossref","first-page":"3853","DOI":"10.1016\/j.febslet.2006.06.009","article-title":"Branchio-oto-renal syndrome associated mutations in Eyes Absent 1 result in loss of phosphatase activity","volume":"580","author":"Rayapureddi","year":"2006","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0530","first-page":"75","article-title":"Hearing loss disorders associated with renal disease","volume":"70","author":"Kimberling","year":"2011","journal-title":"Adv. Otorhinolaryngol."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0535","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/humu.20691","article-title":"Branchio-oto-renal syndrome (BOR): novel mutations in the EYA1 gene, and a review of the mutational genetics of BOR","volume":"29","author":"Orten","year":"2008","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0540","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s004390100495","article-title":"Oto-facio-cervical (OFC) syndrome is a contiguous gene deletion syndrome involving EYA1: molecular analysis confirms allelism with BOR syndrome and further narrows the Duane syndrome critical region to 1cM","volume":"108","author":"Rickard","year":"2001","journal-title":"Hum. Genet."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0545","doi-asserted-by":"crossref","first-page":"5764","DOI":"10.1128\/MCB.01645-09","article-title":"Sipl1 and Rbck1 are novel Eya1-binding proteins with a role in craniofacial development","volume":"30","author":"Landgraf","year":"2010","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0550","doi-asserted-by":"crossref","first-page":"e31327","DOI":"10.1371\/journal.pone.0031327","article-title":"Genes in the ureteric budding pathway: association study on vesico-ureteral reflux patients","volume":"7","author":"van Eerde","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2013.05.022_bb0555","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/hmg\/10.3.195","article-title":"Mutations in the transcriptional activator EYA4 cause late-onset deafness at the DFNA10 locus","volume":"10","author":"Wayne","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0560","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1002\/ajmg.a.31860","article-title":"A novel splice site mutation in EYA4 causes DFNA10 hearing loss","volume":"143A","author":"Hildebrand","year":"2007","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0565","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.ejmg.2009.06.004","article-title":"De novo 9Mb deletion of 6q23.2q24.1 disrupting the gene EYA4 in a patient with sensorineural hearing loss, cardiac malformation, and mental retardation","volume":"52","author":"Dutrannoy","year":"2009","journal-title":"Eur. J. Med. Genet."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0570","first-page":"651","article-title":"Eya4-deficient mice are a model for heritable otitis media","volume":"118","author":"Depreux","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0575","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1161\/01.CIR.101.15.1812","article-title":"Dilated cardiomyopathy and sensorineural hearing loss: a heritable syndrome that maps to 6q23\u201324","volume":"101","author":"Schonberger","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.bbadis.2013.05.022_bb0580","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/ng1527","article-title":"Mutation in the transcriptional coactivator EYA4 causes dilated cardiomyopathy and sensorineural hearing loss","volume":"37","author":"Schonberger","year":"2005","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0585","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1002\/ajmg.a.31793","article-title":"Nonsyndromic hearing loss DFNA10 and a novel mutation of EYA4: evidence for correlation of normal cardiac phenotype with truncating mutations of the Eya domain","volume":"143A","author":"Makishima","year":"2007","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0590","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/art.30130","article-title":"Genome-wide association study of genetic predictors of anti-tumor necrosis factor treatment efficacy in rheumatoid arthritis identifies associations with polymorphisms at seven loci","volume":"63","author":"Plant","year":"2011","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0595","doi-asserted-by":"crossref","first-page":"E946","DOI":"10.1002\/humu.21094","article-title":"EYA4, deleted in a case with middle interhemispheric variant of holoprosencephaly, interacts with SIX3 both physically and functionally","volume":"30","author":"Abe","year":"2009","journal-title":"Hum. Mutat."},{"issue":"2","key":"10.1016\/j.bbadis.2013.05.022_bb1995","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/j.1742-4658.2012.08718.x","article-title":"Small molecule tools for functional interrogation of protein tyrosine phosphatases","volume":"280","author":"He","year":"2013","journal-title":"FEBS J."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0605","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1158\/1940-6207.CAPR-09-0213","article-title":"A novel mechanism of indole-3-carbinol effects on breast carcinogenesis involves induction of Cdc25A degradation","volume":"3","author":"Wu","year":"2010","journal-title":"Cancer Prev. Res."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0610","first-page":"331","article-title":"Technology evaluation: ISIS-113715, Isis","volume":"6","author":"Liu","year":"2004","journal-title":"Curr. Opin. Mol. Ther."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0615","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1749-6632.2010.05836.x","article-title":"New insights in gene-derived therapy: the example of Duchenne muscular dystrophy","volume":"1214","author":"Aartsma-Rus","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bbadis.2013.05.022_bb0620","doi-asserted-by":"crossref","first-page":"S124","DOI":"10.1161\/CIRCULATIONAHA.109.928424","article-title":"MicroRNA-210 as a novel therapy for treatment of ischemic heart disease","volume":"122","author":"Hu","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.bbadis.2013.05.022_bb0625","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.cell.2011.09.029","article-title":"Coding-independent regulation of the tumor suppressor PTEN by competing endogenous mRNAs","volume":"147","author":"Tay","year":"2011","journal-title":"Cell"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443913001841?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443913001841?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,11]],"date-time":"2024-05-11T02:39:20Z","timestamp":1715395160000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443913001841"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":390,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S0925443913001841"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2013.05.022","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protein tyrosine phosphatase variants in human hereditary disorders and disease susceptibilities","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2013.05.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}